Cytovance Biologics Expands Standalone Analytical Services for Biopharmaceutical Clients
Biotechnology and pharmaceutical sponsors navigating tight timelines and complex drug candidates require fast, flexible access to specialized laboratory testing. U.S.-based contract development and manufacturing organization (CDMO) Cytovance Biologics announced the expansion of its portfolio to offer standalone Cytovance Biologics analytical services without requiring clients to commit to a...
0 Comments 0 Shares 76 Views 0 Reviews
Sponsored